Search the Conference Calendar
Closely related topics
Browse by subject
|
Conference Management Software Our Conference Management Software (COMS) can be used for online:
- registration
- payment
- paper submission
- review process
- paper selection
- production of the book of abstracts
Read more ...
Try our demo online
Meetings/Workshops on Molecular Biology in Canada
Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events.
Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!
Meeting organisers can submit meetings free of charge for inclusion into the listing.
Select a location: Argentina (1) - Australia (1) - Belgium (1) - Brazil (1) - Canada (3) - China (2) - Croatia (2) - Czech Republic (1) - Denmark (1) - France (12) - Germany (31) - Greece (3) - India (4) - Ireland (2) - Israel (2) - Italy (15) - Netherlands (5) - Poland (4) - Portugal (1) - Singapore (2) - Spain (13) - Sweden (1) - Switzerland (7) - Turkey (1) - United Kingdom (34) - United States (52) - ALL COUNTRIES (202)
| 1.3rd Conference on Therapeutic Resistance in Cancer | | Dates | 15 Mar 2012 → 17 Mar 2012 | [ID=449655]  | | Location | Montreal, Canada | | Abstract | Clinicians and scientists working in translational cancer research are invited to explore the importance of therapeutic resistance in the pursuit of personalized medicine. | | Topics | cancer, oncology, biomarkers, bioinformatics, therapeutic resistance, clinical resistance, biopsies, clinical trials, biomarker discovery, translational research, personalized medicine | | Weblink | http://www.resistanceincancer2012.com | | Contact | Safran gestion d'évènements, 462 St-Henri Street, Suite 203, La Prairie, Qc, Canada J5R 2S6; Phone: (1-877-840-7717 or (450) 444-7717); Email: services@safranevenements.ca | | Related subject(s) | Oncology; Bioinformatics and Computational Biology |
| 2.Keystone Symposia: Nuclear Receptor Matrix: Reloaded | | Dates | 15 Apr 2012 → 20 Apr 2012 | [ID=428109]  | | Location | Whistler, BC, Canada | | Abstract | Nuclear receptors (NRs) represent a large superfamily of transcription factors that function as ligand-dependent sensors for a diverse set of fat-soluble hormones, vitamins and dietary lipids. Together, NRs govern expression of genes involved in a broad range of reproductive, developmental, metabolic and immune response programs. For this reason, NRs have been investigated for over 20 years as promising targets for drugs to treat a multitude of therapeutic indices, including cancer, diabetes, obesity, cardiovascular disease, hypertension, inflammation and cholestasis. However, despite the success of numerous NR-based therapies, there remain significant hurdles exploiting NRs to develop newer classes of therapies that achieve targeted benefits with reduced side effects. Thus, understanding the mechanisms, transcriptional targets and networks of physiologic pathways that govern NR action has become an important new strategy for evaluating the role of NRs in health and disease. This ?reloaded? effort is now beginning to produce exciting new avenues of research in the field. This meeting will bring together a key group of junior and senior investigators that are exploring these new directions and provide participants with a matrix of unique possibilities for them to investigate in both academic and pharmaceutical laboratory settings. | | Topics | Keystone Symposia, Nuclear, Receptor, Matrix, nucleus, cell, biology | | Weblink | http://www.keystonesymposia.org/12D3 | | Related subject(s) | Biology; Biochemistry and Medicinal Chemistry |
View all listed conferences in Canada.
Last updated: 10 December 2011
|